Opendata, web and dolomites

Vitreoject

Disrupting Medical Instruments for Eye Care.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Vitreoject project word cloud

Explore the words cloud of the Vitreoject project. It provides you a very rough idea of what is the project "Vitreoject" about.

compromising    remained    industry    2004    game    liability    2018    economy    move    efficient    healthcare    eye    million    experimental    strategy    safer    mr    disrupt    rose    sme1    elderly    dabous    saving    operations    introduction    device    feasibility    limited    mostly    risk    drug    solution    reducing    injected    medication    manufactured    parts    mio    invention    formulated    age    hamburg    ophthalmology    disburden    functional    disruptive    global    kromer    medical    financial    commercial    localised    unchanged    strive    original    prototype    2019    adoption    save    visual    ophthalmologists    time    degeneration    filed    macular    impairment    worldwide    integration    april    ug    patent    founded    market    contains    setting    instruments    2017    249    leaders    dr    annually    group    team    sterilisation    vitreoject    optimising    unpredictability    administered    lack    injection    changing    theatre    care    injections    health    validated    transformative    material    viability    yearly   

Project "Vitreoject" data sheet

The following table provides information about the project.

Coordinator
VITREOJECT UG (HAFTUNGSBESCHRANKT) 

Organization address
address: HANS-HENNY-JAHNN-WEG 7
city: HAMBURG
postcode: 22085
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.vitreoject.de
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VITREOJECT UG (HAFTUNGSBESCHRANKT) DE (HAMBURG) coordinator 50˙000.00

Map

 Project objective

Dr Kromer and Mr Dabous founded Vitreoject UG (limited liability) in Hamburg in 2018. Together with our team, we aim to increase access to eye care by improving and optimising process operations. Age-related macular degeneration is the leading cause of visual impairment in the elderly and treated with medication injected into the eye. Before the introduction of the drug, less than 5,000 injections were administered annually. Since then, global numbers rose to more than 90 million worldwide. However, there is a lack of an optimised approach as the injection process has mostly remained unchanged since 2004. With the Vitreoject device, we strive to disrupt the process of these injections by compromising all needed parts into one device, making it more efficient, material-saving and above all, safer. Vitreoject is the only device that allows the game-changing localised sterilisation and integration of all steps into one device. We develop the transformative invention with support from industry leaders from the ophthalmology and economy sector, as well as a leading group of ophthalmologists. Our device has the potential to save € 249 Mio yearly in health care costs in Europe by reducing operating theatre time. The medical device market is a high risk market due to the unpredictability of the product adoption. This SME1 proposal contains a feasibility study on the technical aspects of the product, the commercial strategy, implementation and its financial viability. The original technology concept was formulated in late 2017, and a patent filed in April 2018. The solution is now developed as a functional working prototype that has been validated in an experimental setting, and we would like to use this SME1 feasibility study to be able to advance and move forward to a manufactured product in late 2019. Vitreoject is dedicated to developing disruptive medical instruments for eye care which will be able to disburden the European Healthcare system.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VITREOJECT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VITREOJECT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

SQP (2019)

Opening new markets for Single Quantum Photodetectors

Read More  

ALICE (2019)

Armored Liftable anti-Intrusion Control Equipment

Read More